Regulatory News In Brief

Johnson & Johnson/LifeScan is recalling nearly 2 million blood glucose meters in the U.S. and overseas. Court rules in favor of FDA in Cytori 510(k) substantial equivalence case. More regulatory news.

More from Regulation

More from Policy & Regulation